The BEACON Study (Breast Cancer Outcomes With NKTR-102) (BEACON)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Nektar Therapeutics
ClinicalTrials.gov Identifier:
NCT01492101
First received: December 12, 2011
Last updated: August 2, 2016
Last verified: August 2016